Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

计划入组 30 人 · 首次发布于 2017 年 6 月 15 日

Evaluation in Vivo of Mouthwash With Nanoencapsulated Fluoride

计划入组 21 人 · 首次发布于 2021 年 12 月 3 日

Evaluation in Vivo of Dentifrice With Nanoencapsulated Fluoride

计划入组 20 人 · 首次发布于 2017 年 1 月 2 日

Pegadricase

Sirolimus(Fyarro, Hyftor, Rapamune)

C₅₁H₇₉NO₁₃

Paclitaxel nanoencapsulated

OXYPROS PLUS

United States

Plus Therapeutics

United States

Bumpers Plus

United States

FDA Issues Complete Response Letter for Sobi's Gout Therapy NASP, Citing Manufacturing Issues Only

FDA Accepts Sobi's NASP Biologics License Application for Uncontrolled Gout Treatment

Sobi to Present Clinical Data on Rare Disease Therapies at EULAR 2025